Anticoagulation for Pediatric Mechanical Circulatory Support
- 1 June 2013
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Pediatric Critical Care Medicine
- Vol. 14, S37-S42
- https://doi.org/10.1097/pcc.0b013e318292dfa7
Abstract
Extracorporeal life support applications have evolved considerably in recent years. However, the blood-biomaterial interface remains incompletely understood, and management of the acute inflammatory response and coagulation pathways continues to be challenging. At present, the gold standard for anticoagulation is unfractionated heparin. Since the inception of extracorporeal life support, the mainstay for anticoagulation monitoring has been activated clotting time. However, alongside the technological evolution in extracorporeal life support, the methods for monitoring heparin have also become more sophisticated, adding additional layers of complexity to creating an ideal safe protocol for anticoagulation during extracorporeal life support. To address this, the Extracorporeal Life Support Organization has formed an Anticoagulation Task Force to help direct both a consensus statement and potential guidelines within which the multiple monitoring methods can be customized for extracorporeal life support. One key question that remains in the use of these monitoring methods is whether the objective during extracorporeal life support is to anticoagulate the circuit to prevent thrombus formation within the extracorporeal device or whether it is to systemically anticoagulate the patient. This review details all current monitoring methods and highlights how they can be used during pediatric mechanical circulatory support.Keywords
This publication has 34 references indexed in Scilit:
- Correlations Between Activated Clotting Time Values and Heparin Concentration Measurements in Young Infants Undergoing Cardiopulmonary BypassAnesthesia & Analgesia, 2010
- New Anticoagulants in ChildrenHematology-American Society Hematology Education Program, 2008
- Maintaining the Standard: A Quality Assurance Study for New Equipment in the Michigan ECMO ProgramAsaio Journal, 2007
- Argatroban in Extracorporeal Membrane OxygenationArtificial Organs, 2007
- Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically III childrenHaematologica, 2007
- Assessing Heparin Dosing in Neonates on Venoarterial Extracorporeal Membrane OxygenationAsaio Journal, 2007
- Anticoagulation in the youngHeart, 2004
- Functional Maturity of the Coagulation System in ChildrenAnesthesia & Analgesia, 1997
- Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infantsThe Journal of Pediatrics, 1996
- Defining the heparin-binding domain of antithrombinBlood Coagulation & Fibrinolysis, 1994